Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 13.43M | $93.0M | 13.34% | +3.57M | 2026-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.12M | $56.0M | 8.06% | +3.48M | 2026-06-30 |
| Redmile Group, LLC | 6.89M | $47.0M | 6.84% | +1.35M | 2026-06-30 |
| ORBIMED ADVISORS LLC | 6.31M | $43.0M | 6.26% | -- | 2026-06-30 |
| Prosight Management, LP | 5.96M | $41.0M | 5.91% | +953.4K | 2026-06-30 |
| BlackRock, Inc. | 3.94M | $27.0M | 3.91% | +3.43M | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 3.75M | $26.0M | 3.72% | -- | 2026-06-30 |
| NEXTBio Capital Management LP | 3.73M | $25.0M | 3.70% | +577.4K | 2026-06-30 |
| Deep Track Capital, LP | 3.71M | $25.0M | 3.68% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.21M | $22.0M | 3.18% | +930.7K | 2026-06-30 |
